Journal of Cancer Research and Therapeutics Close
 

Figure 4: Effect of curcumin-loaded nanostructured lipid carriers (Cur-NLC) on vascular endothelial growth factor (VEGF) level in HepG2 cells. After treatment with Cur-NLC for 48 h, the supernatant was collected, and the production of VEGF in culture supernatants was measured by enzyme-linked immunosorbent assay, as described in materials and methods. All values are mean ± standard deviation (n = 3). #P < 0.05, ##P < 0.01 compared with the control group; *P < 0.05, **P < 0.01 compared with the empty nanoparticletreated group (upper graph); *P < 0.05, **P < 0.01 compared with native curcumin group (under graph)

Figure 4: Effect of curcumin-loaded nanostructured lipid carriers (Cur-NLC) on vascular endothelial growth factor (VEGF) level in HepG2 cells. After treatment with Cur-NLC for 48 h, the supernatant was collected, and the production of VEGF in culture supernatants was measured by enzyme-linked immunosorbent assay, as described in materials and methods. All values are mean ± standard deviation (<i>n</i> = 3). #<i>P</i> < 0.05, ##<i>P</i> < 0.01 compared with the control group; *<i>P</i> < 0.05, **<i>P</i> < 0.01 compared with the empty nanoparticletreated group (upper graph); *<i>P</i> < 0.05, **<i>P</i> < 0.01 compared with native curcumin group (under graph)